Results

Total Results: 1,402 records

Showing results for "question".

1181. Archived: Final Evidence Summary: Child Maltreatment: Primary Care Interventions | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary13/child-maltreatment-primary-care-interventions-2013
      January 15, 2013 - Data Synthesis We assessed the aggregate quality of the body of evidence for each key question as good … Key Question 2 What are the adverse effects of behavioral interventions and counseling to reduce harm … From this population, an arrow represents interventions initiated in primary care settings (key question … For key question 1, 11 trials were included, and additional trials from the prior report are discussed … For key question 2, no studies were included.

1182. Evidence Summary: Ovarian Cancer: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/ovarian-cancer-screening
      February 13, 2018 - for ovarian cancer as defined above. 18 The strength of the overall body of evidence for each key question … Benefits of Screening Key Question 1. … with ovarian cancer did not differ significantly between study groups. 21 Harms of Screening Key Question … Effects of Ovarian Cancer Screening on Ovarian Cancer Mortality (Key Question 1)^{Question 2)}

1183. Evidence Summary: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary--html/cardiovascular-disease-screening-using-nontraditional-risk-assessment
      July 10, 2018 - Benefits of Risk Assessment Key Question 1. … Performance Characteristics of Risk Assessment Measures Key Question 2. … Harms of Risk Assessment Key Question 3. … Key Question 5. What are the harms of treatment guided by nontraditional risk factors? … That analysis, while valid, was designed to answer a different question about risk stratification and

1184. Archived: Evidence Summary: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
      March 08, 2004 - We rated the overall body of evidence for each key question using the system developed by the USPSTF. … For key question 2, we included large observational studies that used appropriate statistical methods … For key question 5b, we included clinical trials and observational studies that reported the number of … For question 7b, controlled trials of non-pegylated interferon without ribavirin were also included if … We rated the overall body of evidence for each key question using the system developed by the USPTF.

1185. Archived: Final Evidence Review: Hepatitis B in Pregnant Women: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review48/hepatitis-b-in-pregnant-women-screening
      June 15, 2009 - Key Question 1 What are the benefits of screening for HBV infection in pregnant women? … Key Question 2 What are the harms of screening for HBV infection in pregnant women?

1186. Archived: Final Evidence Review: Hepatitis B in Pregnant Women: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review48/hepatitis-b-in-pregnant-women-screening-2009
      June 15, 2009 - Key Question 1 What are the benefits of screening for HBV infection in pregnant women? … Key Question 2 What are the harms of screening for HBV infection in pregnant women?

1187. Screening for Hepatitis B Virus Infection in Pregnant Women: Evidence for the Reaffirmation Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/mEtSwJk3YPA4BXJ8eZyD2S
      June 01, 2009 - Key Question 1 What are the benefits of screening for HBV infection in pregnant women? … Key Question 2 What are the harms of screening for HBV infection in pregnant women?

1188. Procedure Manual Appendix VII. Criteria for Assessing External Validity (Generalizability) of Individual Studies | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-appendix-vii-criteria-assessing-external-validity-generalizability-individual-studies
      July 01, 2017 - Each study that is identified as providing evidence to answer a key question

1189. Procedure Manual Appendix VII. Criteria for Assessing External Validity (Generalizability) of Individual Studies | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-vii-criteria-assessing-external-validity-generalizability-individual-studies
      July 01, 2017 - Print Each study that is identified as providing evidence to answer a key question

1190. Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening
      September 06, 2016 - Benefits of Screening Key Question 1. … Accuracy and Reliability of Screening Tests Key Question 2. … Benefits of Treatment Key Question 3. … Harms of Screening Key Question 4. Are there harms associated with screening for LTBI? … Harms of Treatment Key Question 5.

1191. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
      September 06, 2016 - Benefits of Screening Key Question 1. … Accuracy and Reliability of Screening Tests Key Question 2. … Benefits of Treatment Key Question 3. … Harms of Screening Key Question 4. Are there harms associated with screening for LTBI? … Harms of Treatment Key Question 5.

1192. Preeclampsia Screening Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgA7neX9UurPQRh3pJaYXY
      April 25, 2017 - Screening Harms Key Question 5. … 1a and Key Question 5) Source, Study Designa Outcome Category Outcome No. … Accuracy of Screening Tests Key Question 4a. … Risk Prediction Key Question 2. … Key Question 3. What are the harms of preeclampsia risk prediction?

1193. Evidence Gaps Research Taxonomy Table: Research Gaps for Screening for Speech and Language Delay and Disorders in Children (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/T6auAz-64DpreTqycmvSJr
      January 01, 2001 - Abbreviations: KQ=key question; RCT=randomized, controlled trial; SES=socioeconomic status; USPSTF=U.S

1194. Final Research Plan: Celiac Disease: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan99/celiac-disease-screening
      November 03, 2014 - Abbreviation: KQ=key question

1195. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
      April 01, 2013 - Summary of Evidence Studies Design Limitations Consistency Applicability Overall Quality Key question … Key question 2: Harms of tamoxifen and raloxifene when used to reduce risk for primary breast cancer … Key question 4: Medication decisions and concordance, adherence, and persistence Decisions: 11 studies … Key question 5: Methods to identify women at increased risk for breast cancer 19 studies of 13 models … 4§ (n = 50) Key question 5§ (n = 21) * Cochrane Central Register of Controlled Trials and Cochrane

1196. Final Research Plan: Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan88/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
      February 18, 2014 - Contextual Question Contextual questions will not be systematically reviewed and are not shown in the

1197. Archived: Final Research Plan: Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan88/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
      February 18, 2014 - Contextual Question Contextual

1198. Shared Decision Making About Screening and Chemoprevention | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/shared-decision-making-about-screening-and-chemoprevention
      January 01, 2017 - At that time, the central question was whether there was high-quality evidence showing that a preventive … harms than had previously been available, the USPSTF was faced with answering a new and more complex question … In time, the USPSTF encountered preventive services for which even this question could not be easily … As confusion began to surround the question of whether "A" and "B" recommendations from the USPSTF meant … Patient participation in the patient-provider interaction: the effects of patient question asking on

1199. Shared Decision Making About Screening and Chemoprevention | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/shared-decision-making-about-screening-and-chemoprevention
      January 01, 2017 - At that time, the central question was whether there was high-quality evidence showing that a preventive … harms than had previously been available, the USPSTF was faced with answering a new and more complex question … In time, the USPSTF encountered preventive services for which even this question could not be easily … As confusion began to surround the question of whether "A" and "B" recommendations from the USPSTF meant … Patient participation in the patient-provider interaction: the effects of patient question asking on

1200. Shared Decision-Making About Screening and Chemoprevention: A Suggested Approach (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/sharedba.pdf
      January 01, 2004 - At that time, the central question was whether there was high-quality evidence showing that a preventive … harms than had previously been available, the USPSTF was faced with answering a new and more complex question … In time, the USPSTF encountered preventive services for which even this question could not be easily … As confusion began to surround the question of whether “A” and “B” recommendations from the USPSTF meant … Patient participation in the patient- provider interaction: the effects of patient question asking on